SpaceWar.com - Your World At War
Iraq gets 336,000 vaccine doses through UN initiative
Baghdad, March 25 (AFP) Mar 25, 2021
Iraq received 336,000 doses of the AstraZeneca vaccine Thursday through the UN's Covax programme, in the second delivery for the Arab state worst hit by the coronavirus epidemic.

The country of 40 million inhabitants that has been ravaged by decades of war launched vaccinations at the start of March with 50,000 Sinopharm jabs donated by China.

With a state budget that has yet to be agreed, Baghdad has remained dependent on donations such as the doses of South Korean-manufactured AstraZeneca vaccine flown in under the Covax-programme for the world's poorer countries.

Covid-19 cases in Iraq have soared, with a new record of 6,513 new confirmed infections in 24 hours, including 33 deaths, registered on Thursday.

Officially, 815,605 cases and 14,128 deaths have been recorded in Iraq, whose health ministry has yet to be allocated a budget.

sbh/hc/dv

ASTRAZENECA


ADVERTISEMENT




Space News from SpaceDaily.com
Trump shifts priority to Moon mission, not Mars
The Quantum Age will be Powered by Fusion
BlackSky accelerates Gen-3 satellite into full commercial service in three weeks

24/7 Energy News Coverage
Conventional photon entanglement reveals thousands of hidden topologies in high dimensions
Philosopher argues AI consciousness may remain unknowable
Introducing the SEVEN Class A Thermopile Pyranometer

Military Space News, Nuclear Weapons, Missile Defense
SDA expands Tracking Layer satellite awards and related missile defense contracts
Rheinmetall ICEYE Space Solutions to provide SAR reconnaissance data to German military
RTX radar selected to support autonomous X 62A fighter testing

24/7 News Coverage
Bible 1.0: How Ancient Canon Became Our First Large Language Models
Can scientists detect life without knowing what it looks like
Deep ocean quakes linked to Antarctic phytoplankton surges



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.